These three products are: Glatiramer Acetate, an immunomodulator drug that is used to treat multiple sclerosis; Lenalidomide used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes and Crizotinib used for treating anaplastic lymphoma kinase. Here, ALK is linked to plasma cell myeloma.